EXACT Sciences to Present at Two Investor Conferences in November
Posted on: Friday, 27 October 2006, 18:00 CDT
EXACT Sciences Corporation (NASDAQ: EXAS) announced today that the Company will be presenting at two investor conferences in November.
On Thursday, November 2, 2006, Don Hardison, EXACT Sciences' President and Chief Executive Officer, will be presenting at the 2006 Mass Opportunities Biotechnology Investment Conference at the Hilton Logan Airport Hotel in Boston, Massachusetts. The presentation will begin at 11:30 a.m. ET.
On Monday, November 6, 2006, Mr. Hardison will be presenting at the Rodman & Renshaw 8th Annual Healthcare Conference at the New York Palace Hotel in New York City. The presentation will begin at 2:30 p.m. ET.
Webcasts of both presentations may be accessed at EXACT Sciences' website, www.exactsciences.com, through the Investor Relations page. Archived versions of the webcasts will be available for 30 days following the live presentations.
About EXACT Sciences
EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings (LabCorp) for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than 20 years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies will help enable detection of colorectal cancer so that more people can be effectively treated. Founded in 1995, EXACT Sciences is based in Marlborough, Mass. PreGen-Plus(TM) has not been approved or cleared by the Food & Drug Administration.
Source: Business Wire
Related Articles
- Aspects Of Media, LLC Effectively Combines Green Screen and Slide Show Technology for Corporate Video Presentations
- EXACT Sciences Corporation to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
- Exact Sciences Provides Regulatory Update for Its Version 2 Stool-Based DNA Technology for Colorectal Cancer Screening
- Exact Sciences Diagnostic Technology Found Effective in Detection of Cancer
- Mount Sinai School of Medicine and EXACT Sciences Announce Publication of Multi-Center Study Results on Stool DNA Testing for Colon Cancer
- EXACT Sciences to Webcast Panel Presentation at the RBC Capital Markets Health Care Conference
- EXACT Sciences to Present at Two Investor Conferences in September
- New Potential Application for Stool DNA Testing Demonstrated in Research Study; EXACT Sciences' Technology Evaluated for Detection of Colorectal Cancer Associated With Inflammatory Bowel Disease
- CollaGenex Pharmaceuticals to Present at the Lazard Capital Markets Life Sciences Conference on November 30th
 |
 |
User Comments (0)
RSS Feeds